Graphene Oxide

Graphene Oxide (GO) is a chemically modified derivative of Graphene — a single-layer sheet of carbon atoms arranged in a two-dimensional hexagonal lattice — in which oxygen-containing functional groups (hydroxyl, epoxide, carbonyl, and carboxyl groups) have been introduced across the carbon surface. This oxidation process makes graphene oxide water-dispersible, highly biocompatible with certain biological systems, and amenable to further chemical functionalisation, properties that have made it an object of intense interest in nanomedicine, materials science, and — following independent research conducted during the COVID-19 pandemic era — in alternative research communities investigating undisclosed components in pharmaceutical products.

Graphene oxide sits at the intersection of Nanotechnology, mRNA Technology, and Biosurveillance concerns. While mainstream scientific literature presents GO primarily as a promising drug delivery platform and biosensor substrate, a growing body of independent research alleges its undisclosed presence in COVID-19 vaccine formulations and raises questions about its potential role in enabling intra-body nanotechnological networks.

Graphene oxide belongs to a broader family of graphene-derived nanomaterials that includes Graphene itself, reduced graphene oxide (rGO), Carbon Nanotubes, and — crucially — graphene quantum dots (GQDs), a zero-dimensional form closely related to GO. See Carbon Quantum Dot for extended treatment of GQDs and their relevance to biomedical and surveillance research. The boundaries between these materials are not always analytically sharp; in practice, a single sample may contain structures ranging from GO sheets to rGO domains to GQDs, all detectable by Raman spectroscopy but requiring careful spectral interpretation to distinguish.

A physical sample of graphene oxide material, showing its characteristic appearance as a dry powder or flake.

Chemical Structure and Properties

Graphene oxide is produced by treating graphite with strong oxidising agents — a process first described by chemist Benjamin Brodie in 1859, and later refined through the Hummers method, which remains the most widely used synthesis route today.

Its key properties include:

• Amphiphilicity: GO contains both hydrophilic (water-attracting) and hydrophobic (water-repelling) regions, enabling it to interact with a wide range of biological and chemical environments.
• Large surface area: A single sheet of GO presents an enormous surface area relative to its mass, allowing it to carry substantial payloads of drugs, genetic material, or other agents.
• Electrical conductivity: Partially reduced graphene oxide (rGO) can conduct electricity, a property with implications for in-body electronic applications. See Intra-Body Nano Network.
• Fluorescence quenching: GO can suppress fluorescence signals, a property exploited in biosensor design. See Biosensors and Surveillance.
• Electromagnetic responsiveness and signal behaviour: GO and rGO structures exhibit sensitivity to specific electromagnetic frequencies, including those within the microwave and terahertz spectrum. Crucially, graphene-family materials have been shown to absorb and re-radiate electromagnetic signals — a property that makes them candidates for antenna-like function within biological systems. Some researchers have proposed this makes GO-based structures responsive to 5G network frequencies and relevant to the emerging field of the Internet of NanoThings, where nanoscale devices communicate via electromagnetic signals within or between bodies. See also Intra-Body Nano Network and Electromagnetic Activation of Nanodevices.
• Self-assembly potential: Under certain conditions of pH, temperature, or electromagnetic stimulation, GO sheets can organise into three-dimensional structures. This self-assembly capacity is considered significant by researchers investigating whether GO could function as a structural backbone for intra-body networks. See Self-Assembling Nanostructures.
• Toxicity profile: GO exhibits dose-dependent cytotoxicity — at certain concentrations it causes oxidative stress, membrane disruption, and cell death. At lower concentrations its effects remain an area of active and contested research. See Nanotoxicology.

The Graphene Family: Situating GO Among Related Nanomaterials

Graphene oxide is best understood not as an isolated material but as one member of an interconnected family of sp²-carbon nanomaterials, each sharing a common structural heritage but differing in dimensionality, degree of oxidation, and functional behaviour.

Comparison of graphene-family nanomaterials: graphene, graphene oxide, reduced graphene oxide, carbon nanotubes, and graphene quantum dots

Graphene

The parent material — a two-dimensional single-atom-thick sheet of carbon atoms — exhibits extraordinary electrical conductivity and mechanical strength. See Graphene.

Reduced Graphene Oxide (rGO)

When GO is chemically or thermally treated to remove some of its oxygen-containing functional groups, the result is rGO — a partially restored graphene lattice with improved electrical conductivity relative to GO but greater structural defect density than pristine graphene. rGO is particularly relevant to discussions of in-body conductive pathways.

Carbon Nanotubes

Carbon Nanotubes (CNTs) are cylindrical rolled-up graphene sheets, representing a one-dimensional carbon nanomaterial. Like GO, CNTs have been investigated extensively for drug delivery and neural interface applications, and share some toxicological concerns regarding biopersistence and pulmonary effects.

Graphene Quantum Dots

Graphene quantum dots (GQDs) are zero-dimensional fragments of the graphene lattice, typically 1–10 nanometres in lateral dimension. They retain the sp²-hybridised carbon structure of graphene and graphene oxide but exhibit quantum confinement effects that produce strong, tuneable photoluminescence — making them attractive for biosensing, bioimaging, and drug delivery applications.

GQDs are closely related to graphene oxide in both composition and synthesis routes: they can be produced by chemical oxidation and fragmentation of graphene oxide sheets, meaning that a graphene oxide synthesis process may yield a mixed product containing both intact GO sheets and GQD fragments. This compositional overlap has significant implications for analytical detection. See Carbon Quantum Dot for full treatment.

The relationship between GO, rGO, and GQDs is not simply categorical — in real-world samples, all three may coexist, and the spectroscopic signatures associated with each can overlap, particularly in the Raman D-band and G-band regions. Independent researchers analysing pharmaceutical vial contents must therefore interpret spectral data carefully to characterise the specific graphene-family species present.

Documented Scientific Applications

Within mainstream nanomedicine and materials science, graphene oxide has been investigated for the following applications:

Drug and Gene Delivery

GO's large surface area and functional groups allow it to bind to a wide range of drug molecules and nucleic acids. Researchers have demonstrated its use as a carrier vehicle for:

• Chemotherapy agents targeting tumour cells
• CRISPR gene-editing components
• Small interfering RNA (siRNA) for gene silencing
• mRNA constructs for vaccine and therapeutic applications

This places GO in direct functional overlap with Lipid Nanoparticles, which serve a similar delivery role in current mRNA vaccine platforms.

Biosensors

GO-based biosensors have been developed for detecting cancer biomarkers, pathogens, and environmental toxins with extraordinary sensitivity. The ability to functionalise GO surfaces with antibodies or DNA probes makes it a versatile substrate for detection applications. See Biosensors and Surveillance.

Neural Interfaces

GO and rGO have been used experimentally as electrode coatings in brain-computer interface research, owing to their biocompatibility with neural tissue and electrical conductivity. Some researchers at institutions including MIT and the University of Manchester have investigated GO-based scaffolds for neural regeneration and recording. See Neural Nanotechnology.

Antibacterial and Antiviral Coatings

GO coatings have demonstrated antibacterial properties and have been applied to medical surfaces and textiles. Some research has explored its antiviral properties, though these findings remain preliminary.

Detection in COVID-19 Vaccines

Raman spectroscopy identifying graphene-family carbon nanomaterials via characteristic D and G band signatures

The most formally documented independent investigation into the presence of graphene oxide in COVID-19 vaccine vials is the Campra Report (2021), authored by Dr. Pablo Campra of the University of Almería, Spain, and published independently following its commission by La Quinta Columna researchers Ricardo Delgado and Dr. José Luis Sevillano.

Methodology

Dr. Campra applied micro-Raman spectroscopy — a well-established analytical technique used across materials science for the identification and characterisation of carbon-based nanomaterials — to the contents of seven COVID-19 vaccine vials from multiple manufacturers. Raman spectroscopy works by detecting the vibrational modes of molecular bonds when stimulated by laser light, producing spectral "fingerprints" specific to given materials.

Graphene-family nanomaterials produce two highly characteristic spectral peaks:

• The G-band (~1584 cm⁻¹): arising from the in-plane vibration of sp²-hybridised carbon atoms in the graphene lattice.
• The D-band (~1344 cm⁻¹): associated with structural defects in the carbon lattice, characteristic of oxidised or functionalised graphene derivatives such as graphene oxide.

The ratio and shape of these two peaks, along with associated secondary bands (notably the 2D band), allow analysts to distinguish between pristine graphene, graphene oxide, reduced graphene oxide, and graphene quantum dots. However, it is important to note that the spectral signatures of GO, rGO, and GQDs share considerable overlap in the D- and G-band regions — a feature that means analytical conclusions must acknowledge the possibility that detected species include any or all members of the graphene family rather than pure GO alone. The Campra Report explicitly acknowledged this, noting the detection of graphene quantum dot-consistent spectra alongside those consistent with GO and rGO. See Carbon Quantum Dot and Nanoparticles in Vaccines.

Key Findings

Dr. Campra's analysis yielded the following results:

• 8 objects were identified as conclusively consistent with graphene oxide based on their Raman spectral signatures matching reference standards for GO.
• A further 20 objects displayed Raman spectra compatible with graphene-family nanomaterials, though with less definitive confidence.
• Structures identified included particles with spectral signatures matching:
  • Reduced graphene oxide (rGO)
  • Graphene quantum dots (GQDs) — zero-dimensional sp²-carbon fragments sharing the graphene lattice structure. See Carbon Quantum Dot.
  • Other carbon-based nanostructures consistent with the graphene family

• Graphene oxide was not declared as an ingredient in any of the Emergency Use Authorisation (EUA) documentation submitted to regulatory bodies including the FDA and EMA for any of the vaccine products examined. Equally, no graphene quantum dots, rGO, or carbon nanotube-class materials were declared.

Dr. Campra characterised the findings as preliminary but warranting urgent independent investigation, noting the limitations inherent in working with small sample sizes and calling for larger-scale spectroscopic studies by independent laboratories with access to unblinded samples.

Significance and Implications

If confirmed by further independent replication, the presence of undisclosed graphene-family nanomaterials — including GO, rGO, and GQDs — in vaccine formulations would represent a significant breach of Informed Consent principles and pharmaceutical transparency requirements. The findings intersect with broader research into:

• The potential role of GO as a carrier scaffold enabling Self-Assembling Nanostructures observed in post-vaccination blood samples.
• The toxicological implications of undisclosed GO and GQD exposure — see Nanotoxicology.
• The hypothesised functional role of GO in enabling Intra-Body Nano Network architectures responsive to external electromagnetic signals.
• The patterns of undisclosed nanomaterial use alleged to characterise what some researchers describe as a coordinated Transhumanist Agenda.
• The broader question of what other graphene-family species — including graphene quantum dots — may be present in pharmaceutical or environmental delivery vectors. See Nanoparticles in Vaccines and Graphene in Vaccines.

See Graphene in Vaccines, COVID Vaccines, La Quinta Columna, Dr. Pablo Campra, Self-Assembling Nanostructures, and Nanotoxicology for extended treatment of these interconnected topics.

Official Response

Pharmaceutical manufacturers and regulatory bodies including the FDA and EMA have consistently denied the presence of graphene oxide in vaccine formulations. Mainstream fact-checking organisations have characterised the claims as misinformation. Independent researchers counter that the methods used to dismiss these findings — primarily reliance on manufacturer declarations rather than independent spectroscopic analysis — are inadequate and constitute a form of regulatory and epistemic capture.

Graphene Oxide in COVID-19 Vaccines: Additional Independent Research

Beyond the Campra Report, several independent researchers have contributed corroborating or contextualising findings in this area.

Dr. Shimon Yanowitz

Dr. Shimon Yanowitz conducted electrical conductivity testing on vaccine vial contents, reporting anomalous results inconsistent with declared biological contents. His work has been cited alongside the Campra findings as corroborating evidence of undisclosed electrically conductive nanomaterials.

Dr. Ana Maria Mihalcea

Dr. Ana Maria Mihalcea has documented what she describes as self-assembling nanostructures in blood samples from vaccinated individuals using darkfield microscopy. Her research repeatedly references graphene oxide as a candidate material for some of the observed formations, citing its self-assembly properties and electromagnetic responsiveness. Some of the fluorescent structures she has described are consistent with the photoluminescent behaviour characteristic of graphene quantum dots. See Self-Assembling Nanostructures and Live Blood Analysis.

Graphene Oxide and the Intra-Body Nano Network

Some researchers have proposed that if graphene oxide is present within biological systems in sufficient quantities, it could serve as a substrate for an Intra-Body Nano Network — a theorised system of nanoscale components operating within the human body and potentially communicating with external networks via electromagnetic frequencies.

The specific properties of GO that make it relevant to this hypothesis include:

• Electrical conductivity: rGO in particular can form conductive pathways within tissue.
• Electromagnetic responsiveness: GO structures may act as antennas capable of receiving or transmitting signals, particularly in the GHz frequency ranges associated with 5G networks. Graphene's demonstrated capacity to absorb and re-radiate electromagnetic energy across a broad spectrum makes it uniquely suited to this hypothesised function within the emerging conceptual framework of the Internet of NanoThings.
• Self-assembly: Under the right conditions, GO sheets organise into larger structures — potentially including antenna-like or circuit-like formations.
• Biocompatibility: GO can persist within biological systems without triggering immediate immune rejection, particularly when functionalised to mimic biological molecules. See Immune Evasion and Nanoparticles.
• Graphene quantum dot integration: Graphene quantum dots, as zero-dimensional counterparts to GO, offer complementary functional properties — including photoluminescence and quantum confinement effects — that could enable optical signalling or sensing functions within a hypothesised intra-body network, operating alongside GO's structural and conductive roles.

According to researchers including Mik Andersen (Corona2Inspect), the structural formations observed in post-injection blood samples are consistent with designed nanotechnological systems utilising graphene-family materials as a core component. See Self-Assembling Nanostructures and Intra-Body Nano Network.

Biological Magnetic Phenomena and Alternative Explanations

Independent researchers documenting apparent magnetic and self-organising phenomena in biological samples — including post-vaccination blood — have noted a range of anomalous observations that do not straightforwardly map onto synthetic graphene oxide alone. Some investigators have raised the additional possibility that biological entities capable of producing magnetite nanoparticles may be contributing to the magnetic effects observed. In particular, Magnetotactic Bacteria — microorganisms that synthesise intracellular chains of iron-based magnetosome crystals to orient themselves along geomagnetic field lines — have been proposed as a candidate biological mechanism that could produce magnetic behaviour in tissue samples. Whether such organisms could be introduced, survive within, or be co-opted by synthetic nanosystems remains an open and largely uninvestigated question among independent researchers.

Additionally, some researchers examining Unusual Biological Filaments and anomalous structures in blood or environmental samples have noted possible parallels with the biology of spirochaete bacteria such as Borrelia burgdorferi, the causative agent of Lyme disease. The capacity of such organisms to form biofilm-like structures, evade immune detection, and produce complex filamentous morphologies has led some investigators to ask whether certain biological filament observations — sometimes attributed entirely to synthetic nanostructures — might involve a microbial component, or whether persistent infection syndromes could interact with or be exacerbated by co-administered nanomaterials. These remain speculative hypotheses requiring rigorous investigation.

Toxicology and Health Concerns

Even within mainstream scientific literature, the toxicology of graphene oxide is a subject of active research and genuine uncertainty.

Graphene oxide nanoparticles and their interaction with biological cells, illustrating potential cytotoxic mechanisms

Documented concerns include:

• Pulmonary toxicity: Inhaled GO particles have been shown to cause lung inflammation and oxidative stress in animal models. This is directly relevant to concerns about Aerosol Delivery of Nanoparticles.
• Genotoxicity: Some studies have identified DNA damage associated with GO exposure at certain concentrations.
• Haematological effects: GO has been shown to interact with red blood cells, potentially causing haemolysis (cell rupture) and aggregation at higher concentrations.
• Oxidative stress: GO is a potent generator of reactive oxygen species (ROS), which at elevated levels damage cellular structures and contribute to inflammation.
• Neurological penetration: Some research suggests GO nanoparticles may cross the blood-brain barrier, raising concerns about neurological effects. See Neural Nanotechnology and Neuroweapons.
• Long-term accumulation: The fate of GO within biological systems over extended timeframes — including whether it is excreted, degraded, or accumulates in organs — remains poorly characterised. See Nanotoxicology.
• Graphene quantum dot toxicity: Graphene quantum dots present a distinct and in some respects more complex toxicological profile than GO sheets. Their nanoscale size enables deep tissue penetration and potential nuclear entry; their photoluminescent properties may interfere with cellular light-dependent processes; and their persistence within biological systems is poorly understood. See Nanotoxicology and Carbon Quantum Dot.

Graphene oxide interaction with biological cells, illustrating oxidative stress and cytotoxic mechanisms at the nanoscale

Regulatory and Disclosure Concerns

A central concern raised by independent researchers is not merely whether GO is present in pharmaceutical or environmental products, but whether its presence is disclosed and whether adequate safety testing has been conducted.

Critics of current regulatory frameworks point to:

• The absence of mandatory nanomaterial disclosure requirements for pharmaceutical products in most jurisdictions — a gap that covers not only graphene oxide but all graphene-family species including graphene quantum dots and Carbon Nanotubes.
• The FDA's track record of regulatory capture by pharmaceutical interests.
• The lack of independent, third-party spectroscopic analysis of vaccine vial contents mandated by regulators.
• The suppression or dismissal of independent research findings without substantive scientific rebuttal.
• The absence of any regulatory framework distinguishing between the distinct toxicological profiles of GO, rGO, GQDs, and related carbon nanomaterials — all of which may have been present in products subject to emergency authorisation. See Nanoparticles in Vaccines and Graphene in Vaccines.

See Informed Consent, Regulatory Capture, and Nanotech Ethics.

Graphene Oxide and Electromagnetic Frequency

One of the more controversial aspects of graphene oxide research concerns its relationship to electromagnetic frequency — specifically whether GO-based structures within biological systems could be activated, modulated, or weaponised via external electromagnetic signals.

Some researchers, including those associated with La Quinta Columna, have proposed that the rollout of 5G telecommunications infrastructure in parallel with COVID-19 vaccine programmes was not coincidental — suggesting that 5G frequencies may interact with GO-based in-body structures to produce biological effects including oxidative stress, altered nerve signalling, or remote modulation of physiological states. Graphene's exceptional broadband electromagnetic absorption and re-radiation properties — documented extensively in materials science literature — provide the physical basis for this hypothesis, and have led researchers to position GO as a key enabling material for the Internet of NanoThings paradigm, in which nanoscale devices embedded in biological or environmental substrates communicate via ambient RF and microwave signals.

While this hypothesis remains highly contested and unproven in peer-reviewed literature, the electromagnetic properties of graphene-family nanomaterials are well-documented within mainstream materials science. See Electromagnetic Activation of Nanodevices and 5G.

Related Topics

• Graphene
• Carbon Quantum Dot
• Carbon Nanotubes
• Nanotechnology
• Lipid Nanoparticles
• mRNA Technology
• COVID Vaccines
• Graphene in Vaccines
• Nanoparticles in Vaccines
• Self-Assembling Nanostructures
• Intra-Body Nano Network
• Internet of Bodies
• Internet of NanoThings
• 5G
• Biosensors and Surveillance
• Neural Nanotechnology
• Nanotoxicology
• Immune Evasion and Nanoparticles
• Aerosol Delivery of Nanoparticles
• Chemtrails
• Brain-Computer Interface
• CRISPR
• Dr. Ana Maria Mihalcea
• Dr. Pablo Campra
• Ricardo Delgado
• La Quinta Columna
• Mik Andersen
• Dr. Shimon Yanowitz
• Informed Consent
• Regulatory Capture
• Electromagnetic Activation of Nanodevices
• Magnetotactic Bacteria
• Borrelia burgdorferi
• Unusual Biological Filaments

External References and Further Reading

• Dr. Pablo Campra — Detection of Graphene in COVID19 Vaccines by Micro-Raman Spectroscopy (2021, independent publication)
• La Quinta Columna — Published reports and video documentation on graphene oxide findings
• Dr. Ana Maria Mihalcea — Ana's Substack: ongoing documentation of blood sample findings and GO-related nanostructure research
• Mik Andersen (Corona2Inspect) — Technical analyses of self-assembling nanostructures and graphene-family material identification
• Novoselov, K.S. & Geim, A.K. (2004) — Foundational graphene research, University of Manchester (Nobel Prize in Physics, 2010)
• Dreyer, D.R. et al. (2010) — The Chemistry of Graphene Oxide, Chemical Society Reviews
• NIH — PubMed-indexed literature on graphene oxide toxicology and nanomedicine applications
• Lim, S.Y. et al. (2015) — Graphene and Carbon-Based Nanostructures as Multifunctional Materials in Drug Delivery, Chemical Communications
• Baker, S.N. & Baker, G.A. (2010) — Luminescent Carbon Nanodots: Emergent Nanolights, Angewandte Chemie (foundational reference on carbon quantum dot photoluminescence)